Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000722648 | SCV002099671 | likely benign | not provided | 2020-11-19 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000722648 | SCV003523345 | benign | not provided | 2024-01-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002535036 | SCV003704718 | benign | Inborn genetic diseases | 2022-07-04 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003908017 | SCV004719347 | likely benign | ARID1A-related condition | 2019-07-26 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Gharavi Laboratory, |
RCV000722648 | SCV000853779 | uncertain significance | not provided | 2018-09-16 | no assertion criteria provided | research |